A detailed history of Chicago Partners Investment Group LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 20,559 shares of IOVA stock, worth $226,765. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,559
Previous 20,559 -0.0%
Holding current value
$226,765
Previous $164,000 17.68%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 23, 2024

BUY
$3.3 - $8.89 $8,870 - $23,896
2,688 Added 15.04%
20,559 $167,000
Q3 2023

Oct 26, 2023

BUY
$4.44 - $8.79 $22,200 - $43,949
5,000 Added 38.85%
17,871 $81,000
Q3 2022

Nov 09, 2022

BUY
$9.53 - $13.11 $19,060 - $26,220
2,000 Added 18.4%
12,871 $106,000
Q2 2022

Aug 04, 2022

BUY
$6.38 - $18.33 $69,356 - $199,265
10,871 New
10,871 $127,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.